Literature DB >> 8362771

Time course of hemodynamic changes and improvement of exercise tolerance after cardioversion of chronic atrial fibrillation unassociated with cardiac valve disease.

I C Van Gelder1, H J Crijns, P K Blanksma, M L Landsman, J L Posma, M P Van Den Berg, F L Meijler, K I Lie.   

Abstract

This study prospectively assessed the time course, magnitude and mechanism of the hemodynamic changes after restoration of sinus rhythm in patients with chronic atrial fibrillation (AF) unassociated with valvular disease. Severe cardiac dysfunction may occur after chronic supraventricular tachycardia in patients with and without underlying cardiac disease. Improvement may follow abolishment of the arrhythmia or adequate slowing of the ventricular rate. Eight patients were studied with a mean previous duration of AF of 10 +/- 9 months. Ejection fraction, exercise capacity and the atrial contribution to the left ventricular filling (only during sinus rhythm) were studied before cardioversion, after cardioversion and 1 week, 1 month and 6 months thereafter. A significant improvement in ejection fraction from 36 +/- 13 to 53 +/- 8% (p < 0.05) occurred at 1 month after cardioversion. Concomitantly, peak oxygen consumption had increased at 1 month, from 20.1 +/- 7 to 25.2 +/- 6 ml/min/kg (p < 0.05). Thereafter, no further improvement in hemodynamic parameters occurred. The atrial systole improved already at 1 week (from 3 +/- 5 to 16 +/- 11%, p < 0.05) and remained unchanged thereafter. Thus, restoration of sinus rhythm was associated with a delayed improvement in ejection fraction and maximal exercise capacity, preceded by an early restoration of atrial contractility and an acute slowing of the heart rate. The discrepancy in time course of restoration of atrial and ventricular function parameters suggests that an intrinsic left ventricular cardiomyopathy is present in patients with AF.

Entities:  

Mesh:

Year:  1993        PMID: 8362771     DOI: 10.1016/0002-9149(93)90352-d

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  41 in total

1.  Left ventricular diastolic function after electrical cardioversion of atrial fibrillation.

Authors:  H J Muntinga; F van den Berg; M G Niemeyer; P K Blanksma; E E van der Wall; H J G M Crijns
Journal:  Heart       Date:  2002-04       Impact factor: 5.994

Review 2.  Chronic and paroxysmal atrial fibrillation: course, prognosis, and stroke risk.

Authors:  T E Cuddy
Journal:  J Thromb Thrombolysis       Date:  1999-01       Impact factor: 2.300

Review 3.  Clinical relevance of silent atrial fibrillation: prevalence, prognosis, quality of life, and management.

Authors:  I Savelieva; A J Camm
Journal:  J Interv Card Electrophysiol       Date:  2000-06       Impact factor: 1.900

4.  Atrial Fibrillation.

Authors: 
Journal:  Curr Treat Options Cardiovasc Med       Date:  2000-08

Review 5.  Symptoms and functional status of patients with atrial fibrillation: state of the art and future research opportunities.

Authors:  Michiel Rienstra; Steven A Lubitz; Saagar Mahida; Jared W Magnani; João D Fontes; Moritz F Sinner; Isabelle C Van Gelder; Patrick T Ellinor; Emelia J Benjamin
Journal:  Circulation       Date:  2012-06-12       Impact factor: 29.690

6.  Reversible cardiomyopathy after radiofrequency ablation of 30-year persistent atrial tachycardia.

Authors:  Atsushi Suzuki; Tsuyoshi Shiga; Kotaro Arai; Morio Shoda
Journal:  BMJ Case Rep       Date:  2013-12-10

7.  Frequency and predictors of tachycardia-induced cardiomyopathy in patients with persistent atrial flutter.

Authors:  Stephen Pizzale; Robert Lemery; Martin S Green; Michael H Gollob; Anthony S L Tang; David H Birnie
Journal:  Can J Cardiol       Date:  2009-08       Impact factor: 5.223

8.  Prospective randomized trial of external versus internal transcatheter cardioversion in patients with chronic atrial fibrillation.

Authors:  K E Paravolidakis; T M Kolettis; G N Theodorakis; I A Paraskevaidis; T S Apostolou; D T Kremastinos
Journal:  J Interv Card Electrophysiol       Date:  1998-09       Impact factor: 1.900

9.  Case 4 - A 67 Year-Old Man with Aortic Regurgitation Who Presented Syncope Followed by Shock.

Authors:  Desiderio Favarato; Luiz Alberto Benvenuti
Journal:  Arq Bras Cardiol       Date:  2016-08       Impact factor: 2.000

Review 10.  Comorbidity of atrial fibrillation and heart failure.

Authors:  Liang-Han Ling; Peter M Kistler; Jonathan M Kalman; Richard J Schilling; Ross J Hunter
Journal:  Nat Rev Cardiol       Date:  2015-12-10       Impact factor: 32.419

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.